1. Home
  2. NTRA
  3. NTRA News

Latest Natera Inc. (NTRA) News on December 22, 2024

Natera (NTRA) Just Flashed Golden Cross Signal: Do You Buy?
NTRA

Zacks

5 days ago

Natera (NTRA) Just Flashed Golden Cross Signal: Do You Buy?

NTRA

MT Newswires

5 days ago

Natera Expands Lawsuit Against NeoGenomics to Include Additional Patent

Court Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomics
NTRA

Business Wire

5 days ago

Court Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomics

What Makes Natera (NTRA) a Top Stock Pick for Billionaire Stanley Druckenmiller?
NTRA

Insider Monkey

5 days ago

What Makes Natera (NTRA) a Top Stock Pick for Billionaire Stanley Druckenmiller?

Natera enrolls 1st patients in SAGITTARIUS clinical trial in colon cancer
NTRA

TipRanks

9 days ago

Natera enrolls 1st patients in SAGITTARIUS clinical trial in colon cancer

Natera Announces Enrollment of First Patients in SAGITTARIUS: a Randomized, Phase III Clinical Trial in Colon Cancer
NTRA

Business Wire

10 days ago

Natera Announces Enrollment of First Patients in SAGITTARIUS: a Randomized, Phase III Clinical Trial in Colon Cancer

Natera and MyOme Announce Launch of iPRS™ for Breast Cancer Risk Assessment
NTRA

Business Wire

13 days ago

Natera and MyOme Announce Launch of iPRS™ for Breast Cancer Risk Assessment

Strong Volume Growth Lifted Natera (NTRA) in Q3
NTRA

Insider Monkey

19 days ago

Strong Volume Growth Lifted Natera (NTRA) in Q3

Why Is Natera, Inc. (NTRA) Among the Best High Growth Healthcare Stocks to Invest In Now?
NTRA

Insider Monkey

20 days ago

Why Is Natera, Inc. (NTRA) Among the Best High Growth Healthcare Stocks to Invest In Now?

Clinical Validation Study on Natera’s Fetal RhD NIPT Published in Obstetrics & Gynecology
NTRA

Business Wire

20 days ago

Clinical Validation Study on Natera’s Fetal RhD NIPT Published in Obstetrics & Gynecology

Guardant awarded nearly $293M in false ad trial against Natera
NTRA

MedTech Dive

20 days ago

Guardant awarded nearly $293M in false ad trial against Natera

Exploring Three High Growth Tech Stocks In The United States
NTRA

Simply Wall St.

23 days ago

Exploring Three High Growth Tech Stocks In The United States

Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients
NTRA

Business Wire

25 days ago

Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients

NTRA

MT Newswires

a month ago

Guardant Health Wins False Advertising Suit Against Natera

Natera to Present New SignateraTM Data in Multiple Abstracts at the San Antonio Breast Cancer Symposium
NTRA

Business Wire

a month ago

Natera to Present New SignateraTM Data in Multiple Abstracts at the San Antonio Breast Cancer Symposium

Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal™
NTRA

PR Newswire

a month ago

Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal™

Natera Issues Statement on Guardant Health Litigation
NTRA

Business Wire

a month ago

Natera Issues Statement on Guardant Health Litigation

Natera Co-Founder and Executive Chairman Matthew Rabinowitz Named 2024 R&D Leader of the Year
NTRA

Business Wire

a month ago

Natera Co-Founder and Executive Chairman Matthew Rabinowitz Named 2024 R&D Leader of the Year

Natera Announces Publication of over 100 Peer-Reviewed Papers on SignateraTM
NTRA

Business Wire

a month ago

Natera Announces Publication of over 100 Peer-Reviewed Papers on SignateraTM

Natera, Inc. (NASDAQ:NTRA) Just Reported And Analysts Have Been Lifting Their Price Targets
NTRA

Simply Wall St.

a month ago

Natera, Inc. (NASDAQ:NTRA) Just Reported And Analysts Have Been Lifting Their Price Targets

Stanley Druckenmiller's Strategic Emphasis on Natera Inc in Q3 2024
NTRA

GuruFocus.com

a month ago

Stanley Druckenmiller's Strategic Emphasis on Natera Inc in Q3 2024

Natera Third Quarter 2024 Earnings: Beats Expectations
NTRA

Simply Wall St.

a month ago

Natera Third Quarter 2024 Earnings: Beats Expectations

Natera Stock Explodes 20% After Record-Breaking Q3--Is This Biotech Giant Just Getting Started?
NTRA

GuruFocus.com

a month ago

Natera Stock Explodes 20% After Record-Breaking Q3--Is This Biotech Giant Just Getting Started?

Natera Inc (NTRA) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance Amid ...
NTRA

GuruFocus.com

a month ago

Natera Inc (NTRA) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance Amid ...

Decoding Natera Inc (NTRA): A Strategic SWOT Insight
NTRA

GuruFocus.com

a month ago

Decoding Natera Inc (NTRA): A Strategic SWOT Insight

Natera (NTRA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
NTRA

Zacks

a month ago

Natera (NTRA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates
NTRA

Zacks

a month ago

Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates

NTRA

Associated Press Finance

a month ago

Natera: Q3 Earnings Snapshot

Natera Reports Third Quarter 2024 Financial Results
NTRA

Business Wire

a month ago

Natera Reports Third Quarter 2024 Financial Results

Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer
NTRA

Business Wire

a month ago

Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer

Natera Inc (NTRA) Q3 2024 Earnings Report Preview: What To Expect
NTRA

GuruFocus.com

a month ago

Natera Inc (NTRA) Q3 2024 Earnings Report Preview: What To Expect

Natera to Participate in Upcoming Investor Conferences
NTRA

Business Wire

a month ago

Natera to Participate in Upcoming Investor Conferences

Natera to Report its Third Quarter 2024 Results on November 12, 2024
NTRA

Business Wire

2 months ago

Natera to Report its Third Quarter 2024 Results on November 12, 2024

Exploring Three High Growth Tech Stocks in the United States
NTRA

Simply Wall St.

2 months ago

Exploring Three High Growth Tech Stocks in the United States

Loss-Making Natera, Inc. (NASDAQ:NTRA) Expected To Breakeven In The Medium-Term
NTRA

Simply Wall St.

2 months ago

Loss-Making Natera, Inc. (NASDAQ:NTRA) Expected To Breakeven In The Medium-Term

All You Need to Know About Natera (NTRA) Rating Upgrade to Strong Buy
NTRA

Zacks

2 months ago

All You Need to Know About Natera (NTRA) Rating Upgrade to Strong Buy

Natera to Present New Renasight Data at ASN Kidney Week 2024
NTRA

Business Wire

2 months ago

Natera to Present New Renasight Data at ASN Kidney Week 2024

Natera Inc. (NTRA): Hedge Funds Are Bullish On This NASDAQ Stock Right Now
NTRA

Insider Monkey

3 months ago

Natera Inc. (NTRA): Hedge Funds Are Bullish On This NASDAQ Stock Right Now

High Growth Tech Stocks To Watch In September 2024
NTRA

Simply Wall St.

3 months ago

High Growth Tech Stocks To Watch In September 2024

Natera, Inc. (NASDAQ:NTRA) Shares Could Be 23% Above Their Intrinsic Value Estimate
NTRA

Simply Wall St.

3 months ago

Natera, Inc. (NASDAQ:NTRA) Shares Could Be 23% Above Their Intrinsic Value Estimate

NTRA

MT Newswires

3 months ago

Update: Natera Says Court Orders Permanent Injunction Against NeoGenomics' RaDaR Assay

NTRA

MT Newswires

3 months ago

Natera Says Court Orders Permanent Injunction Against NeoGenomics' RaDaR Assay

Court Orders Permanent Injunction Against NeoGenomics' Accused RaDaR Assay, as Case Enters New Phase
NTRA

Business Wire

3 months ago

Court Orders Permanent Injunction Against NeoGenomics' Accused RaDaR Assay, as Case Enters New Phase

Should You Be Confident in the Growth Potential of Natera (NTRA)?
NTRA

Insider Monkey

3 months ago

Should You Be Confident in the Growth Potential of Natera (NTRA)?

ESMO 2024: Natera showcases chemotherapy prediction benefit of cDNA test
NTRA

Medical Device Network

3 months ago

ESMO 2024: Natera showcases chemotherapy prediction benefit of cDNA test

Natera Announces Three New Signatera Publications; Includes Groundbreaking Overall Survival Data Published in Nature Medicine and also Released at ESMO
NTRA

Business Wire

3 months ago

Natera Announces Three New Signatera Publications; Includes Groundbreaking Overall Survival Data Published in Nature Medicine and also Released at ESMO

First of its Kind Colorectal Cancer Data from Prospective GALAXY Study Released at ESMO; Demonstrates Signatera's Ability to Predict Overall Survival
NTRA

Business Wire

3 months ago

First of its Kind Colorectal Cancer Data from Prospective GALAXY Study Released at ESMO; Demonstrates Signatera's Ability to Predict Overall Survival

Natera (NTRA) Continued its Incremental Strong Results
NTRA

Insider Monkey

3 months ago

Natera (NTRA) Continued its Incremental Strong Results

DNA Testing Stock Taps AI Amid 85% Surge
NTRA

Investor's Business Daily

3 months ago

DNA Testing Stock Taps AI Amid 85% Surge

Natera to Present New Signatera™ Colorectal Cancer Data at ESMO Showing 10X Advantage in Overall Survival
NTRA

Business Wire

3 months ago

Natera to Present New Signatera™ Colorectal Cancer Data at ESMO Showing 10X Advantage in Overall Survival

What Makes Natera (NTRA) an Investment Bet?
NTRA

Insider Monkey

4 months ago

What Makes Natera (NTRA) an Investment Bet?

Natera (NTRA) Rose After Revenues And Profit Margins Beat Estimates
NTRA

Insider Monkey

4 months ago

Natera (NTRA) Rose After Revenues And Profit Margins Beat Estimates

Billionaire Stan Druckenmiller Is Betting On Natera, Inc. (NTRA)
NTRA

Insider Monkey

4 months ago

Billionaire Stan Druckenmiller Is Betting On Natera, Inc. (NTRA)

Natera to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
NTRA

Business Wire

4 months ago

Natera to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Exploring Three High Growth Tech Stocks in the United States
NTRA

Simply Wall St.

4 months ago

Exploring Three High Growth Tech Stocks in the United States

PepsiCo, Inc. (PEP): Among Morgan Stanley’s Highest Conviction Stocks
NTRA

Insider Monkey

4 months ago

PepsiCo, Inc. (PEP): Among Morgan Stanley’s Highest Conviction Stocks

Natera, Inc. (NTRA): Among Morgan Stanley’s Highest Conviction Stocks
NTRA

Insider Monkey

4 months ago

Natera, Inc. (NTRA): Among Morgan Stanley’s Highest Conviction Stocks

Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
NTRA

GuruFocus.com

4 months ago

Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)

NTRA

MT Newswires

4 months ago

Natera's H2 Guidance Leaves 'Ample Room' for Upside, Morgan Stanley Says

Natera, Inc. (NASDAQ:NTRA) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates
NTRA

Simply Wall St.

4 months ago

Natera, Inc. (NASDAQ:NTRA) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates

Natera Second Quarter 2024 Earnings: EPS Beats Expectations
NTRA

Simply Wall St.

4 months ago

Natera Second Quarter 2024 Earnings: EPS Beats Expectations

Decoding Natera Inc (NTRA): A Strategic SWOT Insight
NTRA

GuruFocus.com

4 months ago

Decoding Natera Inc (NTRA): A Strategic SWOT Insight

NTRA

Thomson Reuters StreetEvents

4 months ago

Q2 2024 Natera Inc Earnings Call

Compared to Estimates, Natera (NTRA) Q2 Earnings: A Look at Key Metrics
NTRA

Zacks

4 months ago

Compared to Estimates, Natera (NTRA) Q2 Earnings: A Look at Key Metrics

NTRA

Associated Press Finance

4 months ago

Natera: Q2 Earnings Snapshot

NTRA

MT Newswires

4 months ago

Natera Q2 Loss Narrows, Revenue Jumps

Natera Reports Second Quarter 2024 Financial Results
NTRA

Business Wire

4 months ago

Natera Reports Second Quarter 2024 Financial Results

Natera to Participate in the Canaccord Genuity 44th Annual Growth Conference
NTRA

Business Wire

5 months ago

Natera to Participate in the Canaccord Genuity 44th Annual Growth Conference

Natera to Report its Second Quarter 2024 Results on August 8, 2024
NTRA

Business Wire

5 months ago

Natera to Report its Second Quarter 2024 Results on August 8, 2024

Natera touts positive results for Merkel cell carcinoma surveillance test
NTRA

Medical Device Network

5 months ago

Natera touts positive results for Merkel cell carcinoma surveillance test

Insider Sale: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)
NTRA

GuruFocus.com

5 months ago

Insider Sale: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)

New MultiCenter Prospective Study Demonstrates Signatera’s Clinical Utility in Merkel Cell Carcinoma
NTRA

Business Wire

5 months ago

New MultiCenter Prospective Study Demonstrates Signatera’s Clinical Utility in Merkel Cell Carcinoma

Natera (NTRA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
NTRA

Zacks

5 months ago

Natera (NTRA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
NTRA

GuruFocus.com

5 months ago

Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)

Natera (NTRA) Soared After a 43% Increase In Revenue
NTRA

Insider Monkey

6 months ago

Natera (NTRA) Soared After a 43% Increase In Revenue

Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy
NTRA

Business Wire

6 months ago

Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy

Natera's (NASDAQ:NTRA) investors will be pleased with their massive 314% return over the last five years
NTRA

Simply Wall St.

6 months ago

Natera's (NASDAQ:NTRA) investors will be pleased with their massive 314% return over the last five years

Insider Sale: CEO and President Steven Chapman Sells 37,500 Shares of Natera Inc (NTRA)
NTRA

GuruFocus.com

6 months ago

Insider Sale: CEO and President Steven Chapman Sells 37,500 Shares of Natera Inc (NTRA)

Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer
NTRA

Business Wire

6 months ago

Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer

Insider Selling: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
NTRA

GuruFocus.com

6 months ago

Insider Selling: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)

NTRA

MT Newswires

6 months ago

Natera Adds New Feature to Prospera Heart Test to Improve Detection of Rejection in Transplant Patients

Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients
NTRA

Business Wire

6 months ago

Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients

Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
NTRA

Business Wire

7 months ago

Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Natera (NTRA) Raised Initial 2024 Guidance in Q1
NTRA

Insider Monkey

7 months ago

Natera (NTRA) Raised Initial 2024 Guidance in Q1

Director Gail Marcus Sells 2,000 Shares of Natera Inc (NTRA)
NTRA

GuruFocus.com

7 months ago

Director Gail Marcus Sells 2,000 Shares of Natera Inc (NTRA)

Director Rowan Chapman Sells Shares of Natera Inc (NTRA)
NTRA

GuruFocus.com

7 months ago

Director Rowan Chapman Sells Shares of Natera Inc (NTRA)

Natera Presents Latest in Transplant Innovation Data Across Multiple Organs at ATC 2024
NTRA

Business Wire

7 months ago

Natera Presents Latest in Transplant Innovation Data Across Multiple Organs at ATC 2024

Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference
NTRA

Business Wire

7 months ago

Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference

Natera Announces New MRD Data in Multiple Tumor Types, to be Presented at ASCO Annual Meeting
NTRA

Business Wire

7 months ago

Natera Announces New MRD Data in Multiple Tumor Types, to be Presented at ASCO Annual Meeting

Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
NTRA

GuruFocus.com

7 months ago

Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)

Decoding Natera Inc (NTRA): A Strategic SWOT Insight
NTRA

GuruFocus.com

7 months ago

Decoding Natera Inc (NTRA): A Strategic SWOT Insight

Why Natera Is 'A Stock To Focus On' Following Its Mighty Beat-And-Raise
NTRA

Investor's Business Daily

7 months ago

Why Natera Is 'A Stock To Focus On' Following Its Mighty Beat-And-Raise

Stocks to Watch Friday: TSMC, Novavax, Nvidia, Goldman Sachs
NTRA

The Wall Street Journal

7 months ago

Stocks to Watch Friday: TSMC, Novavax, Nvidia, Goldman Sachs

Natera Inc (NTRA) Surpasses Analyst Revenue Forecasts in Q1 2024
NTRA

GuruFocus.com

7 months ago

Natera Inc (NTRA) Surpasses Analyst Revenue Forecasts in Q1 2024

NTRA

Associated Press Finance

7 months ago

Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024

Natera, Inc. (NASDAQ:NTRA) Q1 2024 Earnings Call Transcript
NTRA

Insider Monkey

7 months ago

Natera, Inc. (NASDAQ:NTRA) Q1 2024 Earnings Call Transcript

Natera Stock Charges Higher. Positive Cash Flow Arrived Early.
NTRA

Barrons.com

7 months ago

Natera Stock Charges Higher. Positive Cash Flow Arrived Early.

NTRA

Associated Press Finance

7 months ago

Natera: Q1 Earnings Snapshot

Natera Reports First Quarter 2024 Financial Results
NTRA

Business Wire

7 months ago

Natera Reports First Quarter 2024 Financial Results

New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera™ in Breast Cancer
NTRA

Business Wire

8 months ago

New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera™ in Breast Cancer

Share on Social Networks: